Gene · 2804
Papers1,684
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 1,684
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MON-2, a Golgi protein, mediates autophagy-dependent longevity in Caenorhabditis elegans. | Sci Adv | 2021 | 34860542 | PubTator, text mining | PubMed |
| Dysregulation of Microtubule Nucleating Proteins in Cancer Cells. | Cancers (Basel) | 2021 | 34830792 | PubTator, text mining | PubMed |
| Preeclampsia: From Cellular Wellness to Inappropriate Cell Death, and the Roles of Nutrition. | Front Cell Dev Biol | 2021 | 34805141 | PubTator, text mining | PubMed |
Study protocol of an open-label, single arm phase II trial investigating the efficacy, safety and quality of life of neoadjuvant chemotherapy with liposomal irinotecan combined with Oxaliplatin and 5-fluorouracil/Folinic acid followed by curative surgical resection in patients with hepatic Oligometastatic adenocarcinoma of the pancreas (HOLIPANC). | BMC Cancer | 2021 | 34794396 | PubTator, text mining | PubMed |
| The Role of GM130 in Nervous System Diseases. | Front Neurol | 2021 | 34777211 | PubTator, text mining | PubMed |
| Education in thoracic anesthesia. Lessons learned from the European Association of Cardiothoracic Anaesthesiology (EACTA) programs. | Saudi J Anaesth | 2021 | 34764845 | PubTator, text mining | PubMed |
IL-1 Signal Inhibition In Alcoholic Hepatitis (ISAIAH): a study protocol for a multicentre, randomised, placebo-controlled trial to explore the potential benefits of canakinumab in the treatment of alcoholic hepatitis. | Trials | 2021 | 34763711 | PubTator, text mining | PubMed |
| Platelet transcriptome identifies progressive markers and potential therapeutic targets in chronic myeloproliferative neoplasms. | Cell Rep Med | 2021 | 34755136 | PubTator, text mining | PubMed |
| Evaluation of Placentation and the Role of the Aryl Hydrocarbon Receptor Pathway in a Rat Model of Dioxin Exposure. | Environ Health Perspect | 2021 | 34747641 | PubTator, text mining | PubMed |
| Congenital disorder of glycosylation caused by starting site-specific variant in syntaxin-5. | Nat Commun | 2021 | 34711829 | PubTator, text mining | PubMed |
| SARS-CoV-2-host proteome interactions for antiviral drug discovery. | Mol Syst Biol | 2021 | 34709727 | PubTator, text mining | PubMed |
| RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy. | Elife | 2021 | 34702444 | PubTator, text mining | PubMed |
| Purified EDEM3 or EDEM1 alone produces determinant oligosaccharide structures from M8B in mammalian glycoprotein ERAD. | Elife | 2021 | 34698634 | PubTator, text mining | PubMed |
| Potential Molecular Mechanisms of Rare Anti-Tumor Immune Response by SARS-CoV-2 in Isolated Cases of Lymphomas. | Viruses | 2021 | 34696358 | PubTator, text mining | PubMed |
| A single-cell transcriptome atlas of the aging human and macaque retina. | Natl Sci Rev | 2021 | 34691611 | PubTator, text mining | PubMed |
| Regulation of local GTP availability controls RAC1 activity and cell invasion. | Nat Commun | 2021 | 34667203 | PubTator, text mining | PubMed |
| Viruses Run: The Evasion Mechanisms of the Antiviral Innate Immunity by Hantavirus. | Front Microbiol | 2021 | 34659193 | PubTator, text mining | PubMed |
| mTORC2 confers neuroprotection and potentiates immunity during virus infection. | Nat Commun | 2021 | 34650053 | PubTator, text mining | PubMed |
| Component of oligomeric Golgi complex 1 deficiency leads to hypoglycemia: a case report and literature review. | BMC Pediatr | 2021 | 34625039 | PubTator, text mining | PubMed |
| Development and Initial Characterization of Cellular Models for COG Complex-Related CDG-II Diseases. | Front Genet | 2021 | 34603392 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2804/papers?page=21